Modulation of the Microglial Nogo-A/NgR Signaling Pathway as a Therapeutic Target for Multiple Sclerosis

Current therapeutics targeting chronic phases of multiple sclerosis (MS) are considerably limited in reversing the neural damage resulting from repeated inflammation and demyelination insults in the multi-focal lesions. This inflammation is propagated by the activation of microglia, the endogenous i...

Descripción completa

Detalles Bibliográficos
Autores principales: Nheu, Danica, Ellen, Olivia, Ye, Sining, Ozturk, Ezgi, Pagnin, Maurice, Kertadjaja, Stephen, Theotokis, Paschalis, Grigoriadis, Nikolaos, McLean, Catriona, Petratos, Steven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9737582/
https://www.ncbi.nlm.nih.gov/pubmed/36497029
http://dx.doi.org/10.3390/cells11233768

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9737582/
https://www.ncbi.nlm.nih.gov/pubmed/36497029
http://dx.doi.org/10.3390/cells11233768

Ejemplares similares